Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12570725 | ZIKA antibodies and their use | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12569478 | Sequestration compounds for treatment of substance use disorder and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-02-10 | 0 | 31 |
| 12570697 | Cyclic peptide useful in the treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2040-03-25 | 0 | 31 |
| 12570667 | Compounds with antibacterial and anti viral activities | 🖼🧊📄§ | 2026-03-10 | 2041-08-16 | 0 | 31 |
| 12569438 | Nanomaterials containing constrained lipids and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-24 | 0 | 31 |
| 12569509 | Method and composition for preventing and treating viral infections | 🖼🧊📄§ | 2026-03-10 | 2042-04-26 | 0 | 31 |
| 12569516 | Subject-specific tumor inhibiting cells and the use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-08-17 | 0 | 31 |
| 12569522 | Pharmaceutical composition comprising Sutterella wadsworthensis and immune checkpoint inhibitors for treatment of colon cancer | 🖼🧊📄§ | 2026-03-10 | 2045-06-04 | 0 | 31 |
| 12569460 | Application of thyroid hormones and thyroid hormone analogues to preparation of drugs for treating sickle-cell disease | 🖼🧊📄§ | 2026-03-10 | 2042-10-14 | 0 | 31 |
| 12569508 | Antimicrobial compositions and methods of use | 🖼🧊📄§ | 2026-03-10 | 2041-10-13 | 0 | 31 |
| 12569451 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2039-10-17 | 0 | 31 |
| 12569497 | Use of HCN inhibitors for treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2038-04-25 | 0 | 31 |
| 12569453 | Use of tapinarof for the treatment of atopic dermatitis | 🖼🧊📄§ | 2026-03-10 | 2043-02-02 | 0 | 31 |
| 12569465 | Method for activating follicles by means of using small-molecule compound, and preparation thereof | 🖼🧊📄§ | 2026-03-10 | 2041-07-08 | 0 | 31 |
| 12569542 | Treatment of cancer with immune stimulators | 🖼🧊📄§ | 2026-03-10 | 2042-12-12 | 0 | 31 |
| 12569477 | Compositions for synergistically enhancing mitochondrial function | 🖼🧊📄§ | 2026-03-10 | 2042-12-29 | 0 | 31 |
| 12569439 | Bottom-up assembly of synthetic extracellular vesicles | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12569467 | Small molecules that treat or prevent viral infections | 🖼🧊📄§ | 2026-03-10 | 2043-02-17 | 0 | 31 |
| 12569523 | Engineered therapeutic probiotic system and method | 🖼🧊📄§ | 2026-03-10 | 2044-02-04 | 0 | 31 |
| 12569551 | Modified immunogenic proteins | 🖼🧊📄§ | 2026-03-10 | 2042-10-24 | 0 | 31 |
| 12569577 | PSMA-targeting imaging agents | 🖼🧊📄§ | 2026-03-10 | 2040-10-28 | 0 | 31 |
| 12569559 | Engineered dendritic cell and use thereof | 🖼🧊📄§ | 2026-03-10 | 2045-01-18 | 0 | 31 |
| 12569540 | Human recombinant hyposialylated erythropoietin, methods of purification and therapeutic uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-02-19 | 0 | 31 |
| 12569566 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | 🖼🧊📄§ | 2026-03-10 | 2040-02-12 | 0 | 31 |
| 12570752 | Combination therapy with an anti BCMA antibody and a gamma secretase inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-04-09 | 0 | 31 |
| 12569498 | Methods and compositions for the prevention and treatment of ischemia reperfusion injury and infection | 🖼🧊📄§ | 2026-03-10 | 2040-11-06 | 0 | 31 |
| 12569700 | Methods of use of ultra-high dose rate radiation and therapeutic agent | 🖼🧊📄§ | 2026-03-10 | 2043-08-24 | 0 | 31 |
| 12571020 | Genetically engineered microorganisms that overexpress microcin-mge and methods of purification and use | 🖼🧊📄§ | 2026-03-10 | 2041-02-23 | 0 | 31 |
| 12570748 | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-06-13 | 0 | 31 |
| 12570982 | Altering gene expression in modified T cells and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-14 | 0 | 31 |
| 12570959 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-03-10 | 2042-08-30 | 0 | 31 |
| 12570963 | Gene therapies for lysosomal disorders | 🖼🧊📄§ | 2026-03-10 | 2043-04-11 | 0 | 31 |
| 12569548 | RNA construct | 🖼🧊📄§ | 2026-03-10 | 2040-06-18 | 0 | 31 |
| 12569403 | Capsule with reduced powder leakage | 🖼🧊📄§ | 2026-03-10 | 2040-12-03 | 0 | 31 |
| 12570684 | DPAGT1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors | 🖼🧊📄§ | 2026-03-10 | 2041-06-30 | 0 | 31 |
| 12569445 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-11-13 | 0 | 31 |
| 12571812 | Parallel cell processing method and facility | 🖼🧊📄§ | 2026-03-10 | 2043-12-06 | 0 | 31 |
| 12569449 | Cationic lipid compound, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-03-30 | 0 | 31 |
| 12569474 | Compositions and methods for treating anemia | 🖼🧊📄§ | 2026-03-10 | 2043-11-16 | 0 | 31 |
| 12570767 | Sequences of anti-ecto-5′-nucleotidase antibodies | 🖼🧊📄§ | 2026-03-10 | 2042-05-27 | 0 | 31 |
| 12570665 | Compositions comprising fullerenyl mesochlorin nano-photosensitizers with covalently bound antibiotics and their uses in combination therapy | 🖼🧊📄§ | 2026-03-10 | 2040-06-09 | 0 | 31 |
| 12570692 | Oligopeptide linker intermediate and preparation method thereof | 🖼🧊📄§ | 2026-03-10 | 2042-11-01 | 0 | 31 |
| 12570722 | Single alpha chain collagens | 🖼🧊📄§ | 2026-03-10 | 2043-10-26 | 0 | 31 |
| 12569361 | Devices and methods to treat and prevent diverticulitis | 🖼🧊📄§ | 2026-03-10 | 2041-02-25 | 0 | 31 |
| 12570597 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-08-09 | 0 | 31 |
| 12569470 | Vasodilator and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12569515 | Gold-containing agents for the treatment of lung infections | 🖼🧊📄§ | 2026-03-10 | 2041-03-15 | 0 | 31 |
| 12569534 | Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria | 🖼🧊📄§ | 2026-03-10 | 2039-07-30 | 0 | 31 |
| 12569454 | Nucleophilic chemicals useful in the treatment of cisplatin-induced sensory neuropathy and ototoxicity | 🖼🧊📄§ | 2026-03-10 | 2039-12-27 | 0 | 31 |
| 12569452 | Ophthalmic compositions comprising F6H8 | 🖼🧊📄§ | 2026-03-10 | 2044-02-12 | 0 | 31 |